array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(661)
}
["articles"]=>
array(7) {
[0]=>
array(7) {
["title_en"]=>
string(77) "IT & Admin Services to Indian Affiliate by Singapore Entity Not FTS: Delhi HC"
["snippet_en"]=>
string(194) "Delhi High Court rules on income tax and administrative services provided by a Singapore entity to its Indian affiliate. Analysis of the case Commissioner of Income Tax vs. Bio-Rad Laboratories."
["url"]=>
string(99) "https://taxguru.in/income-tax/it-admin-services-indian-affiliate-singapore-entity-fts-delhi-hc.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/24a4d8e8-44c2-4c96-a182-8547617532ae"
["source"]=>
string(10) "taxguru.in"
["publication_date"]=>
string(10) "2023-11-10"
["categories"]=>
array(7) {
[0]=>
string(5) "Taxes"
[1]=>
string(15) "Business Ethics"
[2]=>
string(11) "Tax evasion"
[3]=>
string(46) "Management of Legal and Regulatory Environment"
[4]=>
string(11) "Legislation"
[5]=>
string(5) "Legal"
[6]=>
string(10) "Tax Havens"
}
}
[1]=>
array(7) {
["title_en"]=>
string(75) "Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement"
["snippet_en"]=>
string(300) "Hercules, Calif., and Venlo, the Netherlands, July 26, 2023( GLOBE NEWSWIRE) -- Bio-Rad Laboratories, Inc.( NYSE: BIO and BIOb) and QIAGEN N.V.( NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court"
["url"]=>
string(76) "https://finance.yahoo.com/news/bio-rad-qiagen-announce-patent-201500562.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3d3721dc-43e4-4795-87db-f774b7c41b35"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-07-26"
["categories"]=>
array(5) {
[0]=>
string(16) "Case Settlements"
[1]=>
string(27) "Business Model & Innovation"
[2]=>
string(21) "Intellectual Property"
[3]=>
string(46) "Management of Legal and Regulatory Environment"
[4]=>
string(5) "Legal"
}
}
[2]=>
array(7) {
["title_en"]=>
string(54) "Kashef Qaadri Takes Second Shot at Dublin City Council"
["snippet_en"]=>
string(75) "DUBLIN – Kashef Qaadri will make another bid for the Dublin City Council."
["url"]=>
string(153) "https://www.independentnews.com/news/dublin_news/kashef-qaadri-takes-second-shot-at-dublin-city-council/article_d7a1cb1e-1e44-11ed-8404-6f4e67c84dfb.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f3e457b2-2cda-45b5-a6ef-e8ca6229ac2a"
["source"]=>
string(19) "independentnews.com"
["publication_date"]=>
string(10) "2022-06-26"
["categories"]=>
array(1) {
[0]=>
string(46) "Management of Legal and Regulatory Environment"
}
}
[3]=>
array(7) {
["title_en"]=>
string(64) "Qiagen Sues Bio-Rad to Stave Off Patent Suit on DNA-Tagging Tech"
["snippet_en"]=>
string(254) "Qiagen NV filed a lawsuit Wednesday against Bio-Rad Laboratories Inc. seeking a federal court’ s judgment that Qiagen’ s QIAcuity system, which it says has been used in 48 states to test municipal wastewater for signs of Covid-19, doesn’ t infringe"
["url"]=>
string(101) "https://news.bloomberglaw.com/ip-law/qiagen-sues-bio-rad-to-stave-off-patent-suit-on-dna-tagging-tech"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/54380145-4298-49d2-9f3c-69c88b11fc5e"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2022-04-06"
["categories"]=>
array(7) {
[0]=>
string(27) "Business Model & Innovation"
[1]=>
string(10) "Litigation"
[2]=>
string(21) "Intellectual Property"
[3]=>
string(8) "Verdicts"
[4]=>
string(8) "Epidemic"
[5]=>
string(46) "Management of Legal and Regulatory Environment"
[6]=>
string(5) "Legal"
}
}
[4]=>
array(7) {
["title_en"]=>
string(65) "Bio-Rad Trims Claims From Infringement Suit by Danaher’s Cytiva"
["snippet_en"]=>
string(252) "Bio-Rad Laboratories Inc.’s preparative protein purification system used in biopharmaceutical research doesn’t infringe six of a patent’s eight claims that Danaher Corp.’s Cytiva Sweden is asserting in a Delaware lawsuit, a federal judge ruled."
["url"]=>
string(99) "https://news.bloomberglaw.com/ip-law/bio-rad-trims-claims-from-infringement-suit-by-danahers-cytiva"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fc7f430d-e796-4fce-81d5-a7bc7ceb00a2"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2022-03-15"
["categories"]=>
array(5) {
[0]=>
string(10) "Litigation"
[1]=>
string(21) "Intellectual Property"
[2]=>
string(8) "Verdicts"
[3]=>
string(46) "Management of Legal and Regulatory Environment"
[4]=>
string(5) "Legal"
}
}
[5]=>
array(7) {
["title_en"]=>
string(145) "Ninth Circuit Holds That Statutes Do Not Constitute “Rules or Regulations of the SEC” for Purposes of Sarbanes-Oxley Act Whistleblower Claims"
["snippet_en"]=>
string(164) "Ninth cir holds that rules like FCPA don't quantify as “Rules or Regulations of the SEC” when determining whistleblower SOX violations when filing with the SEC."
["url"]=>
string(117) "https://www.natlawreview.com/article/ninth-circuit-holds-statutes-do-not-constitute-rules-or-regulations-sec-purposes"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/61ce51e5-9e91-41c7-9d47-88971d8afe9a"
["source"]=>
string(16) "natlawreview.com"
["publication_date"]=>
string(10) "2021-10-06"
["categories"]=>
array(6) {
[0]=>
string(15) "Supply & Demand"
[1]=>
string(7) "Scandal"
[2]=>
string(10) "Litigation"
[3]=>
string(11) "Air Quality"
[4]=>
string(46) "Management of Legal and Regulatory Environment"
[5]=>
string(5) "Legal"
}
}
[6]=>
array(7) {
["title_en"]=>
string(71) "Bio-Rad, Harvard settle DNA analysis patent dispute with French company"
["snippet_en"]=>
string(206) "Bio-Rad Laboratories has settled its patent infringement claims against French biotech company Stilla Technologies three days after the start of a trial in Boston federal court, according to a court filing."
["url"]=>
string(126) "https://www.reuters.com/legal/transactional/bio-rad-harvard-settle-dna-analysis-patent-dispute-with-french-company-2021-07-08/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3b60c69a-bc98-4e16-8fcd-86222fa59002"
["source"]=>
string(11) "reuters.com"
["publication_date"]=>
string(10) "2021-07-08"
["categories"]=>
array(9) {
[0]=>
string(16) "Case Settlements"
[1]=>
string(27) "Business Model & Innovation"
[2]=>
string(10) "Litigation"
[3]=>
string(17) "Business Disputes"
[4]=>
string(21) "Intellectual Property"
[5]=>
string(8) "Verdicts"
[6]=>
string(46) "Management of Legal and Regulatory Environment"
[7]=>
string(5) "Legal"
[8]=>
string(21) "Competitive Behaviour"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
661 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Delhi High Court rules on income tax and administrative services provided by a Singapore entity to its Indian affiliate. Analysis of the case Commissioner of Income Tax vs. Bio-Rad Laboratories.
Hercules, Calif., and Venlo, the Netherlands, July 26, 2023( GLOBE NEWSWIRE) -- Bio-Rad Laboratories, Inc.( NYSE: BIO and BIOb) and QIAGEN N.V.( NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court
Qiagen NV filed a lawsuit Wednesday against Bio-Rad Laboratories Inc. seeking a federal court’ s judgment that Qiagen’ s QIAcuity system, which it says has been used in 48 states to test municipal wastewater for signs of Covid-19, doesn’ t infringe
Bio-Rad Laboratories Inc.’s preparative protein purification system used in biopharmaceutical research doesn’t infringe six of a patent’s eight claims that Danaher Corp.’s Cytiva Sweden is asserting in a Delaware lawsuit, a federal judge ruled.
Ninth cir holds that rules like FCPA don't quantify as “Rules or Regulations of the SEC” when determining whistleblower SOX violations when filing with the SEC.
Bio-Rad Laboratories has settled its patent infringement claims against French biotech company Stilla Technologies three days after the start of a trial in Boston federal court, according to a court filing.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
